Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Significance: β-Amyloid aggregates are often found in the brains of Alzheimer’s patients. We have previously reported that β-amyloid levels can be down-regulated through activation of autophagy, a process involving the degradation of unnecessary or harmful proteins. However, the underlying mechanism of β-amyloid autophagy-mediated degradation is unknown. Here we demonstrate that the complex adaptor protein 2/phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (AP2/PICALM), via an interaction with a β-amyloid precursor, bridges β-amyloid degradation and autophagy. This work reveals mechanistic steps for the targeting of the β-amyloid precursor for degradation via autophagy and supports a genome-wide association study identifying PICALM as a risk factor for Alzheimer’s disease (AD). Altogether, these findings support the notion that activating autophagy is a valid approach for the AD field, which urgently needs novel therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, PICALM-guided APP intracellular trafficking to autophagosome for degradation (589) limits A 𝛃 production working in harmony with A 𝛃 transvascular BBB clearance to keep low levels of A 𝛃 in the brain.”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [589]
Experimental — accuracy not yet measuredIn the citing paper
“Similarly, loss‐of‐function mutations affecting PICALM (phosphatidylinositol‐binding clathrin assembly protein) impair autophagy dynamics, thus augmenting the risk for developing AD (Tian et al, 2013).”
From Autophagy in major human diseases (2021) · cites this paper as Tian et al, 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J.-A., Outzen, H., Øvervatn, A., Bjørkøy, G., & Johansen, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702824200 · Cited by 4,578
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Axe, E. L., Walker, S. A., Manifava, M., Chandra, P., Roderick, H. L., Habermann, A., Griffiths, G., & Ktistakis, N. T. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200803137 · Cited by 1,885 · cited 1×
“(1996) The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family.”
BackgroundMitochondria Supply Membranes for Autophagosome Biogenesis during Starvation
Hailey, D. W., Rambold, A. S., Satpute-Krishnan, P., Mitra, K., Sougrat, R., Kim, P. K., & Lippincott-Schwartz, J. (2010) · Cell · doi:10.1016/j.cell.2010.04.009 · Cited by 1,429 · cited 1×
“The membrane origins of autophagosomes are unclear but may include ER (11–13), mitochondria (14), and plasma membrane (15).”
BackgroundNix is a selective autophagy receptor for mitochondrial clearance
Novak, I., Kirkin, V., McEwan, D. G., Zhang, J., Wild, P., Rozenknop, A., Rogov, V., Löhr, F., Popovic, D., Occhipinti, A., et al. (2010) · The EMBO Reports · doi:10.1038/embor.2009.256 · Cited by 1,309
Phosphorylation of the Autophagy Receptor Optineurin Restricts Salmonella Growth
Wild, P., Farhan, H., McEwan, D. G., Wagner, S., Rogov, V. V., Brady, N. R., Richter, B., Korac, J., Waidmann, O., Choudhary, C., et al. (2011) · Science · doi:10.1126/science.1205405 · Cited by 1,298
Trafficking and Proteolytic Processing of APP
Haass, C., Kaether, C., Thinakaran, G., & Sisodia, S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006270 · Cited by 1,075 · cited 3×
“Most APP-βCTF is produced in the endocytic pathway (1).”
BackgroundA Role for NBR1 in Autophagosomal Degradation of Ubiquitinated Substrates
Kirkin, V., Lamark, T., Sou, Y.-S., Bjørkøy, G., Nunn, J. L., Bruun, J.-A., Shvets, E., McEwan, D. G., Clausen, T. H., Wild, P., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.020 · Cited by 1,065
Spilman, P., Podlutskaya, N., Hart, M. J., Debnath, J., Gorostiza, O., Bredesen, D., Richardson, A., Strong, R., & Galvan, V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009979 · Cited by 1,033
Endoproteolysis of Presenilin 1 and Accumulation of Processed Derivatives In Vivo
Thinakaran, G., Borchelt, D. R., Lee, M. K., Slunt, H. H., Spitzer, L., Kim, G., Ratovitsky, T., Davenport, F., Nordstedt, C., Seeger, M., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80291-3 · Cited by 1,013 · cited 3×
“RU-369, a rabbit polyclonal antibody that recognizes the C-terminal of APP695 (29); Ab14 antiserum targeting residues 1–25 of PS1-NTF (30); and monoclonal GFP antibody was produced by the monoclonal antibody core facility at Memorial Sloan–Kettering Cancer Center.”
Method
Cited by
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357
“PICALM binds to autophagosomes, suggesting that PICALM may also play a role in autophagy-mediated Aβ clearance (126).”
Cargo recognition and trafficking in selective autophagy
Stolz, A., Ernst, A., & Dikic, I. (2014) · Nature Cell Biology · doi:10.1038/ncb2979 · Cited by 1,207
Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities
Menzies, F. M., Fleming, A., Caricasole, A., Bento, C. F., Andrews, S. P., Ashkenazi, A., Füllgrabe, J., Jackson, A., Jimenez Sanchez, M., Karabiyik, C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.01.022 · Cited by 1,134
“Through its action in a complex with assembly polypeptide 2 (AP2), PICALM may act as an autophagy receptor, which is able to interact with LC3 and target APP into autophagosomes (Tian et al., 2013).”
Metadata
- Authors
- Tian, Y., Chang, J. C., Fan, E. Y., Flajolet, M., & Greengard, P.
- Affiliations
- Rockefeller University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-09-25
- Volume
- 110
- Issue
- 42
- Pages
- 17071-17076
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3801056
- OpenAlex
- W2094702043
- Cited by
- 233
- References
- 32
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 15 · 2023: 20 · 2022: 15 · 2021: 20 · 2020: 31 · 2019: 16 · 2018: 22 · 2017: 18 · 2016: 22 · 2015: 13 · 2014: 13 · 2013: 1
- FWCI
- 11.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fisher Center for Alzheimer's Research Foundation
- National Institutes of Health
- National Institute on Aging (AG09464, R01AG047781, P01AG009464)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- Alzheimer's disease, amyloid-beta clearance, autophagy, adaptor protein 2, PICALM, LC3, endocytic pathway, ATG5, protein degradation
- MeSH terms
- Autophagy-Related Protein 5, Alzheimer Disease, Autophagy, HeLa Cells, Humans, Microtubule-Associated Proteins, Risk Factors, Amyloid beta-Protein Precursor, Adaptor Protein Complex 2, Monomeric Clathrin Assembly Proteins, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy. https://app.cochat.ai/papers/10.1073/pnas.1315110110
- The paper
- Tian, Y., Chang, J. C., Fan, E. Y., Flajolet, M., & Greengard, P. (2013). Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1315110110
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.